Foot And Ankle Specialist Of Georgia, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 3400 Chapel Hill Rd, Suite 321, Douglasville, GA 30135 Phone: 678-741-5346 Fax: 678-999-3030 |
Jennifer S Price, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 8855 Hospital Dr., Ste. 150, Douglasville, GA 30134 Phone: 678-838-4443 Fax: 678-838-4083 |
Norman I Kornblatt, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 3666 Highway 5, Ste 101, Douglasville, GA 30135 Phone: 770-942-3668 Fax: 770-920-9675 |
Village Podiatry Group, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 8855 Hospital Dr Ste 150, Douglasville, GA 30134 Phone: 678-838-4443 Fax: 678-838-4083 |
Watson And Cowans Foot And Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 3387 Highway 5 Ste H, Douglasville, GA 30135 Phone: 800-891-4930 Fax: 770-741-0775 |
Dr. Danielle Matrece Green-watson, DPM Podiatrist - Foot & Ankle Surgery Medicare: May Accept Medicare Assignments Practice Location: 3387 Highway 5 Ste H, Douglasville, GA 30135 Phone: 404-217-2700 |
Zia Mustafa, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 8855 Hospital Dr., Ste. 150, Douglasville, GA 30134 Phone: 678-838-4443 Fax: 678-838-4083 |
News Archive
People who live in areas of higher than average deprivation are more likely to be admitted to hospital and to spend longer in hospital, according to new research from the University of Cambridge.
Hapten Sciences, Inc., a privately held biotechnology company, announced today that it has filed an Investigational New Drug (IND) application and is now planning to initiate dosing of healthy volunteers in a first-in-human Phase 1 clinical trial of its lead product candidate, PDC-APB, a novel, first-in-class, compound in development for a new indication to prevent contact dermatitis due to exposure to poison ivy, oak, and sumac.
University of Nevada, Reno neuroscientists are working with Renown Health to bring new research capabilities to northern Nevada. The research group, led by University Professor of Psychology Michael Webster, has purchased equipment that augments the existing 3T magnetic resonance imaging (MRI) technology at Renown Health for studies of human brain function.
As the COVID-19 pandemic caused by the coronavirus severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) continues to spread around the world, many researchers are studying epidemiological models to predict its propagation. As of yet, there are no effective vaccines that could counter the SARS- CoV-2 infection or drugs to treat COVID-19 disease
Cancer Research UK's Drug Development Office has launched a clinical trial* to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat.
› Verified 9 days ago